Rubra Pharmaceuticals Limited
IT services provider for pharmaceutical, cosmetic, and food industries.
1995 | Active
Rubra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.60 Cr
- Revenue Growth 4.08%
- Profit Growth 41.97%
- Ebitda 5.82%
- Net Worth 23.54%
- Total Assets 11.98%
About Rubra Pharmaceuticals
Rubra Pharmaceuticals Limited (RPL) is a Public Limited Indian Non-Government Company incorporated in India on 31 May 1995 and has a history of 29 years and ten months. Its registered office is in Na, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹9.60 Cr.
Nirupa Gupta, Narender Gupta, and Kapil Gupta serve as directors at the Company.
Company Details
- Location Na, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24200TG1995PLC020538
- Company No.
020538
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 May 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Rubra Pharmaceuticals Limited
Explore comprehensive data for Rubra Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Rubra Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirupa Gupta  | Director | 31-May-1995 | Current |
| Narender Gupta | Director | 31-May-1995 | Current |
| Kapil Gupta | Director | 02-Jan-2003 | Current |
Financial Performance of Rubra Pharmaceuticals.
Rubra Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.08% increase. The company also saw a substantial improvement in profitability, with a 41.97% increase in profit. The company's net worth Soared by an impressive increase of 23.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rubra Pharmaceuticals?
In 2022, Rubra Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Divya Agro Roller Flour Mills Private Limited
Narender Gupta and Kapil Gupta are mutual person
- Varka Labs Private Limited
Kapil Gupta is a mutual person
Charges (Loans)
Open Charges
₹96.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 9.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2013 | Bank Of Maharashtra | ₹9.60 Cr | Open |
How Many Employees Work at Rubra Pharmaceuticals?
Unlock and access historical data on people associated with Rubra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rubra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rubra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Rubra Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Rubra Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Rubra Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge with Bank Of Maharashtra amounted to Rs. 96.00 M with Charge ID 10481315 was registered on 20 Jul 2013.
- Director Appointment
Kapil Gupta was appointed as a Director was appointed as a Director on 02 Jan 2003 & has been associated with this company since 22 years 3 months .
- Director Appointment
Nirupa Gupta was appointed as a Director was appointed as a Director on 31 May 1995 & has been associated with this company since 29 years 10 months .
- Director Appointment
Narender Kumar Gupta was appointed as a Director was appointed as a Director on 31 May 1995 & has been associated with this company since 29 years 10 months .
Frequently asked questions
What is the Incorporation or founding date of Rubra Pharmaceuticals Limited?
Rubra Pharmaceuticals Limited was incorporated on 31 May 1995.
What is authorized share capital and paid-up capital of Rubra Pharmaceuticals Limited?
The authorized share capital of Rubra Pharmaceuticals Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Rubra Pharmaceuticals Limited?
Currently 3 directors are associated with Rubra Pharmaceuticals Limited.
- Nirupa Gupta
- Narender Kumar Gupta
- Kapil Gupta
What is the registered address of Rubra Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Rubra Pharmaceuticals Limited is 4-3-64/1 Raghuth Bagh.K.S.Lane Sultan Bazar, Hyderabad. Telanga India, Na, Telangana.
What is the corporate identification number (CIN) and company number of Rubra Pharmaceuticals Limited?
The corporate identification number (CIN) of Rubra Pharmaceuticals Limited is U24200TG1995PLC020538 and the company number is 020538 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Rubra Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Rubra Pharmaceuticals Limited has risen by 4.08%.
What change has been observed in the net worth of Rubra Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Rubra Pharmaceuticals Limited has experienced an upsurge of 23.54%.
What are the total open charges for Rubra Pharmaceuticals Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Rubra Pharmaceuticals Limited amount to ₹ 9.60 Cr.
When was the last Balance Sheet of Rubra Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Rubra Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records